Search results “Ixempra breast cancer lead investigator”
TRACO 2014 - Breast cancer; Radiation oncology
TRACO 2014 - Breast cancer; Radiation oncology Air date: Monday, October 20, 2014, 4:00:00 PM Category: TRACO Runtime: 01:59:59 Description: TRACO Recent advances in understanding cancer biology are beginning to be translated into improvements in diagnosis and treatment of cancer. In the post-genome era, we increasingly rely on strong collaboration between basic and clinical scientists to develop novel approaches for treatment of human disease. The NCI Center for Cancer Research (CCR) is one of the largest cancer research organizations in the world, with more than 200 principal investigators, and has played a major role in development and implementation of many new technologies, such as nanotechnology, next generation sequencing, genomics and proteomics. For more information go to http://ccr.cancer.gov/careers.courses/traco Author: F. Zia; A. Krauze Permanent link: http://videocast.nih.gov/launch.asp?18687
Views: 964 nihvcast
Dr. Brufsky on the Results of a Study of Trastuzumab and Eribulin for HER2+ MBC
Adam M. Brufsky, MD, PhD, professor of medicine, associate chief, Division of Hematology/Oncology, University of Pittsburgh, discusses the results of a phase II study that looked at the effect of prior trastuzumab on eribulin mesylate in combination with trastuzumab as first-line treatment for HER2-positive locally recurrent or metastatic breast cancer. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 37 Targeted Oncology